FDAFDA · Food and drugs·Recall number D-0318-2023
TPN (a) 100GM/AA, 285GM/DEX, (b)55GM/LIP 2300ML, (c)55GM/AA 285GM/DEX 50GM/LIP1800ML, (d)TPN AA:100GM DEX:250GM LIP:50GM 2400ML, (e) 55GM DEX:285GM 1800ML, Rx Only, use with Curlin pump or no pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320
Published February 22, 2023 · Recall initiated: December 27, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of sterility assurance
What to do
Voluntary: Firm initiated · Telephone
Recall details
- Manufacturer
- Sentara Infusion Services
- Distributor
- Dispensed to Patients Nationwide.
- Lot
- Beyond Use Date: December 24-3 , 2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.